rethinkTHC Search
Menu
Study breakdown

Daily Inhaled Cannabis Linked to Higher Odds of Asthma and COPD in Nearly 380,000 Adults

Cross SectionalModerate evidence
The takeaway

In a nationally representative sample of nearly 380,000 adults, daily inhaled cannabis was associated with 44% higher odds of asthma and 27% higher odds of COPD, even after adjusting for tobacco use.

Cannabis consumers concerned about respiratory health.

44% higher asthma odds with daily inhaled cannabis

What the researchers found

Daily inhaled cannabis was associated with higher odds of asthma (aOR 1.44) and COPD (aOR 1.27) after adjusting for tobacco use. Among 221,767 never-tobacco-users, the asthma association persisted (aOR 1.51) while COPD showed elevated but non-significant odds (aOR 1.54).

Why it matters

This is one of the largest studies examining cannabis and pulmonary disease independent of tobacco. The finding that asthma associations persist even in never-tobacco-users strengthens the case that inhaled cannabis itself may contribute to respiratory disease.

The numbers in context

n=379,049; n=23,035 cannabis users. Daily cannabis and asthma: aOR 1.44 overall, 1.51 in never-tobacco users. Daily cannabis and COPD: aOR 1.27 overall.

How the study worked

Cross-sectional analysis of 2016-2020 BRFSS nationally representative survey. 379,049 adults aged 18-74. Multivariable logistic regression adjusted for sociodemographics and tobacco use. Pre-specified subanalysis in never-tobacco users.

What this study cannot tell us

Cross-sectional. Self-reported diagnoses. No information on product type or method beyond 'inhaled.' Residual confounding possible.

How to read the evidence

Moderate: very large nationally representative sample with tobacco adjustment, but cross-sectional and self-reported outcomes.

When this study was published

Published in 2025, with data from 2016-2020.

The bigger picture

As legalization expands, understanding respiratory risks becomes urgent. This study suggests inhaled cannabis may be an independent risk factor for asthma and possibly COPD, which could influence harm reduction messaging about consumption methods.

Questions still open

  • Would switching to vaporizing reduce risk?
  • Is the asthma risk reversible with cessation?
  • Do non-inhaled products avoid pulmonary risks?

Common questions

Can smoking cannabis cause asthma?
This large study found daily inhaled cannabis associated with 44% higher odds of asthma, even after accounting for tobacco use. Among never-tobacco-users, the association was slightly stronger (51%).
Is inhaled cannabis bad for your lungs?
This study of nearly 380,000 adults found associations between inhaled cannabis and both asthma and COPD, suggesting inhaled cannabis may be a modifiable risk factor for respiratory disease.

Read the original research

Inhaled Cannabis, Asthma, and Chronic Obstructive Pulmonary Disease: A Population-Based Cross-Sectional Study of n = 379,049.

Journal of general internal medicine

Citation

Rustagi, Alison S; Jeffers, Abra M; Graham, F Julian; Cohen, Beth E; Slatore, Christopher G; Byers, Amy L; Glantz, Stanton A; Keyhani, Salomeh. (2025). Inhaled Cannabis, Asthma, and Chronic Obstructive Pulmonary Disease: A Population-Based Cross-Sectional Study of n = 379,049.. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-09833-8

Explore the wider topic